Italo received his PhD in Biochemistry from the University of Rome “La Sapienza” in Italy. In 2007, he moved to Philadelphia to start his post-doctoral research at the Wistar Institute, working in the laboratory for Dr. Paul Lieberman. In 2012, Italo joined the Fels Institute for Cancer Research and Molecular Biology at Temple University as Assistant Professor. In July 2018, Italo was promoted to Associate Professor.
Lisa Beatrice Caruso
Lisa received her Ph.D from La Sapienza University of Rome, where she worked in Alfredo Colosimo’s lab on the use of topological networks in the study of protein structure dynamics and function. After her Ph.D she worked as Volunteer Researcher in the Department of Biochemical Sciences of La Sapienza University of Rome, on a predictive study, through network analysis, of amino acidic residues relevant from a structural and functional point of view in the Protein disulfide isomerase family. She joined the Tempera’s lab in October 2016 and she is currently working on several projects, among those, the identification and characterization of viral DNA-NL interactions during EBV latency and the determination of the relationship between NL association and EBV gene expression.
Michael graduated from the University of Edinburgh in 2012 with an MSc in Biomedical Sciences. Following this, he spent two years working for AstraZeneca in their oncology department analyzing pharmacodynamic endpoints as part of drug discovery research projects. He subsequently spent a year at MedImmune working in Analytical Development to introduce and validate assays for Influenza vaccine quality control. He is now in Dr. Tempera’s lab where he has been focused on understanding the mechanisms by which Epstein-Barr Virus Latent Membrane Protein 1 modifies host gene expression.
Sarah earned her B.S. in Biology at Loyola University Maryland and conducted her undergraduate research in vaccine development against CCHFV. Her current research is focused on identifying key viral and host proteins involved in epigenetic modifications during latent EBV infection and their possible dynamic interactions.
Sarah received her MSc in Biology at the University of Texas. Then spent 10 years in Michael Edidin’s lab at Johns Hopkins University studying protein trafficking in T cells using biophysical methods. Sarah then spent 7 years at Children’s Hospital of Philadelphia working on ER stress proteins in a biochemistry lab. She has also spent a year in Gene Therapy Program at UPENN studying gene therapy methods on various disease models. Sarah joined Tempera lab in August of 2018 and is focused on working on characterizing various EBV associated protein interactions using immunofluorescence microscopy and gene editing.
Vered graduated with a BS from the University of Maryland-College Park and conducted undergraduate research in the use of the CRISPR/Cas9 system for gene editing in Leishmania spp. Her current research focuses on LMP1/PARP1 signaling in Epstein-Barr Virus infected B cells. Vered joined Tempera lab in May of 2019 and her current research focuses on LMP1/PARP1 signaling in Epstein-Barr Virus infected B cells.
Lena Lupey – Green